8.1000
27-November-24 09:38:45
15 minutes delayed
Stocks
+0.1000
+1.25%
Today's range
7.9400 - 8.1000
ISIN
BE0974358906
Source
Cboe
Nyxoah receives FDA approval for full-body 1.5T and 3T MRI compatibility for the Genio® system to treat Obstructive Sleep Apnea (OSA)
09 Feb 2021 01:00:13 By Nasdaq GlobeNewswire
Nyxoah and Vanderbilt University enter exclusive licensing agreement regarding next generation neurostimulation technologies to treat Obstructive Sleep Apnea (OSA)
02 Feb 2021 00:56:05 By Nasdaq GlobeNewswire
Nyxoah announces full-body 1.5T and 3T MRI compatibility for the Genio® system to treat Obstructive Sleep Apnea (OSA)
26 Jan 2021 01:02:09 By Nasdaq GlobeNewswire
First US patient implanted in the DREAM pivotal IDE study, with the Genio® system for the treatment of Obstructive Sleep Apnea (OSA)
05 Jan 2021 01:39:42 By Nasdaq GlobeNewswire